• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CORTISOL; ENZYME IMMUNOASSAY, CORTISOL, SALIVARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CORTISOL; ENZYME IMMUNOASSAY, CORTISOL, SALIVARY Back to Search Results
Catalog Number ASKU
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/16/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer stated that they performed a comparison study for 30 patient samples tested for cortisol and cortisol ii on an e170 analyzer.The customer was questioning results for one sample in particular, since there was a large result difference between the two assays.Of the provided data, a total of eleven patient samples had erroneous results that were reported outside of the laboratory for cortisol.The cortisol results were reported outside of the laboratory and the results from the cortisol ii assay were believed to be correct.The cortisol ii assay is not sold in the united states, nor is it like or similar to products sold in the united states.The first patient serum sample initially resulted as 13.7 ug/dl when tested with cortisol.The sample resulted as 8.95 ug/dl when tested with cortisol ii.The second patient serum sample initially resulted as 10.3 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 5.42 ug/dl when tested with cortisol ii.The third patient serum sample initially resulted as 16.78 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 10.85 ug/dl when tested with cortisol ii.The fourth patient saliva sample initially resulted as 2.96 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 0.54 ug/dl when tested with cortisol ii.The fifth patient saliva sample initially resulted as 6.73 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 2.8 ug/dl when tested with cortisol ii.The sixth patient saliva sample initially resulted as 4.13 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 1.7 ug/dl when tested with cortisol ii.The seventh patient saliva sample initially resulted as 3.67 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 1.78 ug/dl when tested with cortisol ii.The eighth patient saliva sample initially resulted as 5.67 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 2.59 ug/dl when tested with cortisol ii.The ninth patient saliva sample initially resulted as 14.7 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 9.49 ug/dl when tested with cortisol ii.The tenth patient serum sample initially resulted as 25.45 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 16.34 ug/dl when tested with cortisol ii.The eleventh patient serum sample initially resulted as 27.24 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 17.61 ug/dl when tested with cortisol ii.The patients were not adversely affected.The e170 analyzer serial number was asked for, but not provided.Investigations have determined that an old cortisol calibration was in use at the time of the event.No general reagent issue was detected.
 
Manufacturer Narrative
Investigations state that with the launch of the cortisol ii assay, the formerly used polyclonal antibody was replaced by a monoclonal antibody, which is more specific and shows a lower cross-reactivity profile.The cortisol ii assay is also standardized against different reference material, which ensures accurate results.This standardization is the reason that a shift in patient results will be observed when switching from cortisol to cortisol ii.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CORTISOL
Type of Device
ENZYME IMMUNOASSAY, CORTISOL, SALIVARY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5532911
MDR Text Key41427478
Report Number1823260-2016-00368
Device Sequence Number1
Product Code NHG
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
K070788
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2016
Initial Date FDA Received03/29/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/08/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-